- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-24-0001741

About Apnar Pharma Private Limited
Data last updated:
Apnar Pharma Private Limited is a private limited company based in Padra, Gujarat, India, a subsidiary of Apnar Pharma Lp. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U73100GJ2014PTC081520. Its GSTIN is 24AANCA0939J1ZK (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹7.6 Cr and a paid-up capital of ₹7.55 Cr. It was formerly known as Apnar Research Pharma Private Limited. It is led by directors including Umesh Patel and Dharmesh Bhikhabhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block No. 102 At & Po. Gavasad Padra Jambusar Road, Gujarat, India – 391430.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.22 Cr, a decline of 48% compared to the previous year. For the same year it recorded a net loss of ₹68.65 Lakh (net margin -4.8%) and EBITDA of ₹4.24 Cr (EBITDA margin 29.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 21% over five years.
The company has about 128 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Apnar Pharma. As per MCA filings, the company has open charges of ₹50.35 Cr on record. Court records list 9 cases involving the company, including 9 filed against it. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2019. The company has 15 MSME Form 1 returns on record between 2018 and 2024, listing 4,417 overdue payments to 203 micro and small suppliers.
Apnar Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0001741). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apnarpharma.com.
Company details
Recognitions & Rankings of Apnar Pharma
Contact details
Apnar Pharma Private Limited's registered office is in Padra, Gujarat. Its website is apnarpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBlock No. 102 At & Po. Gavasad Padra Jambusar Road, Gujarat, India – 391430
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Apnar Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Apnar Pharma operates one associated brand: Apnar Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. | apnarpharma.com |
Business activity
The main business activity of Apnar Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Apnar Pharma Private Limited, buy the company report.
Financials of Apnar Pharma Private Limited
FY 2025 filings availableApnar Pharma Private Limited reported revenue of ₹14.22 Cr (down 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 48% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.24 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹68.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.8% | ||||
| Net Profit Margin | -4.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apnar Pharma Private Limited, buy the company report.
Board of directors of Apnar Pharma Private Limited
Apnar Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umesh Patel | Director | 25 Feb 2015 | 11 Years 8 Months | Current |
| Dharmesh Bhikhabhai Patel Also directs: Apken Api Private Limited | Director | 24 Jan 2015 | 11 Years 9 Months | Current |
| Swapnil Kantibhai Patel Also directs: Apken Api Private Limited | Director | 12 Dec 2014 | 11 Years 11 Months | Current |
Auditor
Apnar Pharma Private Limited is audited by SHAH SANGHVI & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHAH SANGHVI & ASSOCIATES | FY 2024 | 140107W |
Shareholding
The shareholding of Apnar Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apnar Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jun 2022 | 100595339 | Others | ₹7.5 Cr | Open | |
| 09 Dec 2021 | 100519438 | Others | ₹83.38 Lakh | Open | |
| 24 Aug 2020 | 100371015 | Others | ₹1.66 Cr | Open | |
| 26 May 2020 | 100347326 | Hdfc Bank Limited | ₹19.87 Cr | Open | |
| 16 Dec 2017 | 100145635 | Others | ₹11.49 Cr | Open |
To see the full charge records of Apnar Pharma Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Apnar Pharma Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2019.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Rights issue | ₹70 Lakh | Investors: Apnar Pharma LP |
| Mar 2017 | Rights issue | ₹2.99 Cr | Investors: Apnar Pharma LP |
| Feb 2017 | Secondary share transfer | Undisclosed | Buyer: Apnar Pharma LP Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Apnar Pharma Private Limited has 9 court cases on record: 9 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 9 | 0 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (COMMS) | Filed against the company by Shriji Polymers (India) Limited | Disposed |
| District court, South West, Delhi | Civil suit | Filed against the company by M/S Mechmaark Filtech India Pvt Ltd | Disposed |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed against the company by Government Labour Officer T.J.Pandya | Disposed |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Government Labour Officer T.J.Pandya | Disposed |
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by Aditya Birla Capital Limited | Disposed |
To see the full case history of Apnar Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Apnar Pharma Private Limited has 15 MSME Form 1 returns on record between 2018 and 2024, listing 4,417 overdue payments to 203 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 203)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Gayatri Industrial Gases | |||
| an individual supplier | |||
| Samvedna BMW Incinerator | |||
| an individual supplier |
To see the full MSME payment records of Apnar Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Apnar Pharma Private Limited has a workforce of 128 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 128 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Apnar Pharma Private Limited, buy the company report.
GST
Apnar Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AANCA0939J1ZK | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Apnar Pharma Private Limited, buy the company report.
Recent activity
Apnar Pharma Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Kantibhai Bavabhai Patel ceased to be Director on 05 Sep 2024.
4 earlier events are in the company report.
Frequently asked questions
Apnar Pharma is an active private limited company based in Padra, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2014 (12+ years old) and is registered under CIN U73100GJ2014PTC081520.
Apnar Pharma has 3 current directors:
- Umesh Patel - Director
- Dharmesh Bhikhabhai Patel - Director
- Swapnil Kantibhai Patel - Director
The latest financial statements of Apnar Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Apnar Pharma is 24AANCA0939J1ZK, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Apnar Pharma is U73100GJ2014PTC081520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apnar Pharma has 9 court cases on record: 9 filed against it.
Apnar Pharma was incorporated on 12 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Apnar Pharma has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2019.
Kantibhai Bavabhai Patel ceased to be Director on 05 Sep 2024. Bhavesh Kishor Jagtap ceased to be Additional Director on 17 Aug 2023. Umesh Patel was appointed as Director on 25 Feb 2015. Apnar Pharma has 5 board changes on record in total.
Yes, Apnar Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-24-0001741).
Apnar Pharma has 15 MSME Form 1 returns on record between 2018 and 2024, listing 4,417 overdue payments to 203 micro and small suppliers. The latest return was filed on 02 May 2024.

